Latest Innovation News

Nufarm Limited reported a 3% revenue increase and a 17% rise in underlying EBIT for HY25, driven by strong crop protection volumes and improved cost management. However, net debt climbed 12%, pushing leverage to 4.5 times, highlighting ongoing financial balancing acts.

Nufarm reported a mixed 1H25 with a strong rebound in crop protection profits contrasting a sharp decline in seed technologies earnings, prompting a strategic review of the latter business.

Talga Group has successfully raised A$10 million through a strategic share placement to advance its Vittangi Anode Project, supported by key institutional investors and board members.

Nufarm Limited reported a 3% revenue increase to $1.81 billion for the half-year ended March 2025, driven by Crop Protection volume growth. However, net profit after tax fell 39% amid fish oil pricing pressures and higher operating costs, prompting the board to withhold an interim dividend.

EMVision Medical Devices has enhanced its AI-powered stroke diagnostic algorithm, achieving a notable 95% sensitivity and 80% specificity in recent tests. This progress sets the stage for upcoming pivotal trials and regulatory milestones.

Light & Wonder unveiled ambitious growth targets and strategic plans at its 2025 Investor Day, spotlighting strong financial momentum and the integration of Grover Charitable Gaming. The company aims for $1.4 billion consolidated AEBITDA in 2025, underpinned by robust R&D and market leadership.

SEEK Limited projects strong FY25 revenue and earnings in the top half of guidance, driven by AI-powered product innovation and expanded market reach across Asia-Pacific.

Plenti Group Limited reported a stellar FY25 with a 126% surge in Cash NPAT to $13.8 million, driven by robust loan portfolio growth and operational efficiency. The fintech lender is targeting a $3 billion loan book by March 2026, leveraging technology and strategic partnerships.

Plenti Group Limited reported a robust FY25 with a 126% jump in Cash NPAT to $13.8 million and a 19% increase in its loan portfolio to $2.5 billion, driven by technology enhancements and strategic partnerships.

LTR Pharma has appointed Associate Professor Darren Katz, a leading urologist and erectile dysfunction expert, to its Scientific Advisory Board, aiming to fast-track the development and commercialization of its innovative nasal spray treatments SPONTAN and ROXUS.

Webjet Group posted a solid FY25 financial performance with underlying EBITDA up 1% despite a 7% drop in bookings, supported by growth in international travel and disciplined cost management. The company maintains a strong cash position and sets FY26 guidance in line with current results.

Nufarm Limited reported a solid half-year performance with a 3% revenue increase and a 40% jump in underlying EBIT, driven by strong crop protection sales and cost improvements. However, net debt rose 12%, reflecting investments in omega-3 production and seed technology expansion.